← all drugs
Meperidine Hydrochloride Injection
in shortage · Analgesia/Addiction · Snapshot: 2026-10-09
Day 497
of this shortage, counting from the FDA's first posting on 05/30/2025
- Manufacturers listed
- Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
- Machine-readable
- JSON for this drug
Presentations (6)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-15 — Meperidine Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-08-27 — Meperidine Hydrochloride Injection: availability wording revised for 1 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.